ResMed Inc (RMD)

Operating profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating income	US$ in thousands	1,687,390	1,319,890	1,131,870	1,000,290	903,678
Revenue	US$ in thousands	5,146,330	4,685,300	4,222,990	3,578,130	3,196,820
Operating profit margin		32.79%	28.17%	26.80%	27.96%	28.27%

June 30, 2025 calculation

Operating profit margin = Operating income ÷ Revenue
= $1,687,390K ÷ $5,146,330K
= 32.79%

The operating profit margin of ResMed Inc over the specified period exhibits a pattern of fluctuations within a relatively narrow range, with initial figures recorded at 28.27% on June 30, 2021, and a slight decline to 27.96% by June 30, 2022. This marginal decrease suggests a modest compression of operating profitability during this interval. Continuing into June 30, 2023, the margin further declined to 26.80%, indicating a continued, albeit small, downturn in operating efficiency or cost management.

However, the subsequent year, leading up to June 30, 2024, shows a recovery to 28.17%, surpassing the previous year’s figures and signaling a rebound in operating performance. The most notable change is observed in the period ending June 30, 2025, when the operating profit margin significantly increases to 32.79%. This upward trajectory suggests an improvement in operating leverage, cost control, or revenue enhancement strategies that positively impacted profitability.

Overall, the data illustrates a relatively stable operating profit margin across the initial years with minor declines, followed by a marked improvement in the most recent year, which could reflect operational efficiencies, strategic initiatives, or favorable market conditions contributing to enhanced profitability.